Jefferies Group LLC restated their hold rating on shares of Clorox Company (The) (NYSE:CLX) in a research note issued to investors on Friday. Jefferies Group LLC currently has a $132.00 price target on the stock, down from their previous price target of $137.00. Jefferies Group also issued estimates for Clorox Company (The)’s Q1 2018 earnings at $1.39 EPS, Q2 2018 earnings at $1.32 EPS, Q3 2018 earnings at $1.22 EPS, FY2018 earnings at $5.55 EPS and FY2020 earnings at $6.25 EPS.

Several other research firms have also weighed in on CLX. BMO Capital Markets reiterated a buy rating and issued a $150.00 price objective on shares of Clorox Company (The) in a research note on Thursday, October 5th. Zacks Investment Research lowered Clorox Company (The) from a hold rating to a sell rating in a research note on Wednesday, October 4th. Barclays PLC reiterated an equal weight rating and issued a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Royal Bank Of Canada reiterated a hold rating and issued a $115.00 price objective on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Finally, BidaskClub upgraded Clorox Company (The) from a strong sell rating to a sell rating in a research note on Monday, July 31st. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. Clorox Company (The) currently has an average rating of Hold and a consensus price target of $127.39.

Clorox Company (NYSE CLX) opened at 127.82 on Friday. The company has a market cap of $16.50 billion, a P/E ratio of 23.96 and a beta of 0.40. The firm’s 50-day moving average price is $134.30 and its 200-day moving average price is $134.50. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. During the same period in the previous year, the company posted $1.30 earnings per share. The company’s quarterly revenue was up 2.9% compared to the same quarter last year. Analysts expect that Clorox Company will post $5.64 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Clorox Company (The) (CLX) Rating Reiterated by Jefferies Group LLC” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/10/10/clorox-company-the-clx-rating-reiterated-by-jefferies-group-llc.html.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 2.63%. The ex-dividend date of this dividend is Tuesday, October 24th. Clorox Company (The)’s dividend payout ratio is 63.04%.

In other Clorox Company (The) news, EVP James E. Foster sold 9,861 shares of the company’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the transaction, the executive vice president now owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Jon M. Balousek sold 9,223 shares of the company’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares in the company, valued at approximately $2,862,666.18. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 21,242 shares of company stock worth $2,944,449. Company insiders own 1.00% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of Clorox Company (The) by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after purchasing an additional 369,918 shares during the period. BlackRock Inc. lifted its stake in shares of Clorox Company (The) by 1,402.2% in the 1st quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after purchasing an additional 9,698,542 shares during the period. State Street Corp lifted its stake in shares of Clorox Company (The) by 2.2% in the 1st quarter. State Street Corp now owns 7,648,999 shares of the company’s stock valued at $1,031,304,000 after purchasing an additional 167,689 shares during the period. Wells Fargo & Company MN lifted its stake in shares of Clorox Company (The) by 5.3% in the 2nd quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock valued at $587,934,000 after purchasing an additional 221,168 shares during the period. Finally, Valueinvest Asset Management S.A. lifted its stake in shares of Clorox Company (The) by 6.9% in the 1st quarter. Valueinvest Asset Management S.A. now owns 1,580,400 shares of the company’s stock valued at $213,085,000 after purchasing an additional 102,300 shares during the period. 71.33% of the stock is currently owned by institutional investors.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.